Chemical identity

Lansoprazole N-(3-Methyl-4-Trifluoroethoxyl-Pyridin-2-yl) Impurity

CAS 1083100-26-8 · C25H22F6N4O3S

01Identity

Identifiers and names for this exact compound. Empty fields are left unassigned.

Lazychem IDLC-18134
PubChem CID71750632
NameLansoprazole N-(3-Methyl-4-Trifluoroethoxyl-Pyridin-2-yl) Impurity
CAS RN1083100-26-8
Molecular formulaC25H22F6N4O3S
Molecular weight572.53 g/mol
IUPAC nameN-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl Lansoprazole
InChIKeyGUWVDDXKNHBOLX-UHFFFAOYSA-N

02Structure identifiers

2D structurePubChem CID 71750632
2D structure: Lansoprazole N-(3-Methyl-4-Trifluoroethoxyl-Pyridin-2-yl) Impurity, CAS 1083100-26-8
Structure of Lansoprazole N-(3-Methyl-4-Trifluoroethoxyl-Pyridin-2-yl) Impurity (CAS 1083100-26-8). LazyChem record. Source identity: PubChem CID 71750632. Confirm the identifiers before analytical use.Download structure image

Structure facts for this exact identity.

Molecular formulaC25H22F6N4O3S
InChIKeyGUWVDDXKNHBOLX-UHFFFAOYSA-N
Ring count4
Defined stereocentres0
Unassigned stereocentres1
SMILESCC1=C(C=CN=C1CN2C3=CC=CC=C3N=C2S(=O)CC4=NC=CC(=C4C)OCC(F)(F)F)OCC(F)(F)F
InChIInChI=1S/C25H22F6N4O3S/c1-15-18(32-9-7-21(15)37-13-24(26,27)28)11-35-20-6-4-3-5-17(20)34-23(35)39(36)12-19-16(2)22(8-10-33-19)38-14-25(29,30)31/h3-10H,11-14H2,1-2H3

03Stereochemistry

The published structure contains 0 defined and 1 unassigned tetrahedral stereocentre. The exact wedge-and-dash depiction is shown above.

Defined stereocentres02D structure
Unassigned stereocentres12D structure
Assignment statusUnassignedExact published identity
Tetrahedral upper bound≤ 2Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04India status for this compound

These results apply only to this exact compound name and CAS number. Confirm the current official instruments before making a regulatory decision.

NDPS / RCSNOT FOUND IN REVIEWED ENTRIESCAS 1083100-26-8 was not found in the reviewed exact-identity entries. Generic, class, analogue, salt and isomer provisions were not evaluated.
SCOMETNOT FOUND IN REVIEWED CAS ENTRIESCAS 1083100-26-8 was not found in the reviewed exact-CAS mapping. Generic and analogue entries were not evaluated.

05Names and relationships

Associated parent compound

Lansoprazole

View API and impurity family

Other names

  • 1-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]-2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]benzimidazole
  • 1-((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)-2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole
  • 1H-Benzimidazole, 1-((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)-2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-
  • 1-[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole
  • Lansoprazole Impurity
  • Lansoprazole Impurity P
  • Lansoprazole N-(3-Methyl-4-Trifuoroethoxyl-Pyridin-2-yl) Impurity

Related records from the same parent family

06Documented history

Dated discovery, occurrence, use and issue claims are published only when a suitable primary or government source is available.

No dated history available

No verified discovery, first report, occurrence, use or issue event is currently available for this identity.

07Sources